Objective: HIV-HBV co-infection is a major public health problem that has not been sufficiently explored in the Central African workplace. The aim of this study was to assess the frequency of HIV-HBV co-infection among people who living with HIV (PLHIV) in the infectious and tropical diseases department of the CentreHospitalierUniversitairedel’AmitiéSino-Centrafricaine in Bangui. Methods: A retrospective study was carried out from January 1, 2010 to December 31, 2021 in the Infectious and Tropical Diseases Department at the Amitié Sino-Centrafricaine University Hospital. It included the files of all PLHIV, which included the results of HBV serology. A standardized form was used to collect socio-demographic and professional data by documentary review. Data was analysed using Epi-Info 7 software. Means, proportions were calculated as well as Chi square witch was significant if p-value was below 0.05. Results: The study included 265 patients, 188 were women (70.1%) and 77 men (29.1%), giving a sex ratio of 0.45. Mean age was 35.8 years, higher in men (40 years) than in women (35.8 years) (p ˂ 0.0001). The age groups 25 to 34 (37.7%) and 35 to 44 (33.6%) were in the majority (71.3%). The majority of PLHIV were unemployed (57.1%), including housewives (43.0%). HBV prevalence was 14.3%, including 7.2% among the unemployed, who account for half of all co-infections. The search for associations between HIV-HBV co-infection and all socio-demographic characteristics (age, sex, marital status) and socio-professional categories showed no significant difference (p ≥ 0.05). Conclusion: PLHIV were predominantly young adults, female, and unemployed; no occupation was significantly associated with co-infection. The vast majority of co-infected people were not covered by the occupational health system (unemployed or informal sector). Urgent action is needed to improve workers’ access to occupational medicine in CAR.
References
[1]
WHO (2023) Hepatitis B: Hey Facts. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
[2]
UNAIDS (2022) Fact Sheet Global HIV Statistics. UNAIDS, Geneva. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
[3]
WHO (2017) New Hepatitis Data Highlight Need for Urgent Global Response. WHO, Geneva. https://www.afro.who.int/news/new-hepatitis-data-highlight-need-urgent-global-response
[4]
WHO (2016) Global Health Sector Strategy on Viral Hepatitis. WHO, Geneva. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
[5]
Mossoro-Kpinde, C.D., Gbangba-Ngai, E., Mossoro-Kpinde, H.D., Camengo, Police, S.M., Kobangue, L., Selehina, E., Mbale, M. and Baïpo, F. (2016) Dépistage de l’antigene HBs chez les malades du VIH à Bangui. RevueBio-Africa, 15, 39-43.
[6]
Gachara, G., Magoro, T., Mavhandou, L., Lum, E., Kimbi, H.K., Ndip, N.R. and Bessong, P.O. (2017) Characterization of Occult Hepatitis B Virus Infection among HIV Positive Patient in Cameroon. AIDS Research and Therapy, 14, Article No. 11. https://doi.org/10.1186/s12981-017-0136-0
[7]
Global Burden Disease 2015 HIV Collaborators (2016) Estimates of Global, Regional, and National Incidence, Prevalence and Mortality of HIV, 1980-2015: The Global Burden of Disease Study 2015. The Lancet HIV, 3, e361-e387.
[8]
Bonacci, M., Louie, S., Bzowej, N. and Wohl, A.R. (2004) Survival in Patients with HIV Infection and Viral Hepatitis B or C: A Cohort Study. AIDS, 18, Article ID: 203945. https://doi.org/10.1097/00002030-200410210-00008
[9]
Magaji, F.A., Okolo, M.O., Yiltok, E.S., Golit, W., Anzaku, S.A., Ogwuche, J., Pam, V.C., Ocheke, A.N., Musa, J., Isichie, C., Imade, G.E., Mutihir, J.T., Ugwu, B.T., Agbaji, O., Sagay, S.A., Zoakah, A.I. and Cohn, S.E. (2021) Prevalence of Hepatitis B Virus Infection in Pregnant Women with an without HIV in Jos, Nigeria.International Journal of Infectious Diseases, 104, 276-281. https://doi.org/10.1016/j.ijid.2020.12.058
[10]
UNAIDS (2022) Country HIV Fact Sheet: Central African Republic. UNAIDS, Geneva. https://www.unaids.org/en/regionscountries/countries/centralafricanrepublic
[11]
Komas, N.P., Vickos, U., Hübschen, J.M., Béré, A., Manirakiza, A., Muller, C.P. and Le Faou, A. (2013) Cross-Sectional Study of Hepatitis B Virus Infection in Rural Communities, Central African Republic. BMC Infectious Diseases, 13, Article No. 286. https://doi.org/10.1186/1471-2334-13-286
[12]
Komas, N.P., Ghosh, S., Abdou-Chekaraou, M., Pradat, P., Al Hawajri, N., Manirakiza, A., Laghoe, G.L., Bekondi, C., Brichler, S., Ouavéné, J.O., Sépou, A., Yambiyo, B.M., Gody, J.C., Fikouma, V., Gerber, A., Samarakoon, N.A., Alfaiate, D., Scholtès, C., Martel, N., Le Gal, F., Lo Pinto, H., Amri, I., Hantz, O., Durantel, D., Lesbordes, J,L., Gordien, E., Merle, P., Drugan, T., Trépo, C., Zoulim, F, Cortay, J.C., Kay, A.C. and Dény, P. (2018) Hepatitis B and Hepatitis D Virus Infections in the Central African Republic, Twenty-Five Years after a Fulminant Hepatitis Outbreak, Indicate Continuing Spread in Asymptomatic Young Adults. PLOS Neglected Tropical Diseases, 12, e0006377. https://doi.org/10.1371/journal.pntd.0006377
[13]
Basimane-Bisimwa, P., Koyaweda, G.W., Vickos, U., Ngaïganam, E., Vickos, U., Demi, Sibiro, O.A., Yambiyo, .B.M., Sombié, B.S., Pélembi, P., Moussa, S., Bekondi, C., Giles-Vernick, T., Manirakiza, A., Vray, M. and Komas, N.P.J. (2023) Seroprevalence and Molecular Characterization of Viral Hepatitis and HIV Co-Infection in the Central African Republic. https://doi.org/10.1101/2023.08.24.23294539 https://www.medrxiv.org/content/10.1101/2023.08.24.23294539v1.full.pdf
[14]
Longo, J., Tékpa, G., Diemer, H., Gbangba-Ngaï, E., Sambéla, S., Camengo, Police, S.M. and Grésenguet, G. (2017) Aspects épidémiologiques des hépatites virales B et C au cours de l’infection à VIH en zone de conflits en Centrafrique. Annales de l’Université de Bangui Série D, 3, 50-55.
[15]
Packo, D.S.S., Tomlbaye, F.O., Conde, A., Diakite, M., Kouandogui, F. and Camengo-police, S.M. (2022) Caracteristiques épidémiologiques et cliniques des donneurs de Sang co-infectés par les virus VIH et VHB au Centre National de Transfusion Sanguine de Bangui. Health Science Disease, 23, 46-48.
[16]
Komas, N.P., Baï-Sepou, S., Manirakiza, A., Léal, J., Béré, A. and Le Faou, A. (2010) The Prevalence of Hepatitis B Virus Markers in a Cohort of Students in Bangui, Central African Republic. BMC Infectious Diseases, 10, Article No. 226. https://doi.org/10.1186/1471-2334-10-226
[17]
Nambei, W.S., Rawago-Mandjiza, D. and Gbangba-Ngai, E. (2016) Séroépidémiologie du VIH, de la syphilis et des virus des hépatites B et C chez les donneurs de sang à Bangui, République centrafricaine. Médecine et Santé Tropicales, 26, 192-198. https://doi.org/10.1684/mst.2016.0553
[18]
Schwartz, D. (1960) Méthodes statistiques à l’usage des médecins et biologistes. Revue de Statistique Appliquée, 8, 5-27. http://www.numdam.org/item?id=RSA_1960__8_3_5_0
[19]
Makanera, A., Dramou, I., Sidibe, S., Conde, M., Sy, O., Camara, L.B., Diallo, M.A., Barry, A.O., Camara, D., Diakite, T., Conde, M. and Samake, A.T. (2019) Séroprévalence de la co-infection VIH /virus de l’hépatite B à l’Hôpital de l’Amitié sino-guinéenne (HASIGUI) Kipé/Conakry (Guinée). Journal of Applied Biosciences, 135, 13798-13807. https://doi.org/10.4314/jab.v135i1.6
[20]
Mandiwana, A. and Tshitenge, S. (2017) Prevalence of Human Immunodeficiency Virus-Hepatitis B Virus Co-Infection amongst Adult Patients in Mahalapye, Ngami, Serowe, Botswana: A Descriptive Cross-Sectional Study. South African Family Practice, 59, 94-97. https://doi.org/10.1080/20786190.2016.1272230
[21]
Dovonou, C.A., Amidou S.A., Kpangon, A.A., Traoré, Y.A., Godjedo, T.P.M., Satondji, A.J., Wachinou, A.P., Issa-Djibril, F.M., Fourn, L., Zannou, D.M. and Gandaho, P. (2015) Prévalence de l’hépatite B chez les personnes infectées par le VIH à Parakou au Bénin. The Pan African Medical Journal, 20, Article No. 125. https://doi.org/10.11604/pamj.2015.20.125.6061
[22]
Kye-Duodu, G., Nortey, P., Malm, K., Nyarko, K.M., Sackey, S.O., Ofori, S. and Afari, E.A. (2016) Prevalence of Hepatitis B Virus Co-Infection among HIV-Seropositive Persons Attending Antiretroviral Clinics in the Eastern Region of Ghana. The Pan African Medical Journal, 25, 7. https://doi.org/10.11604/pamj.supp.2016.25.1.6172
[23]
Öztürk, S., Özel, A.S., Ergen, P., Şenbayrak, S. and Ağalar, C. (2022) Hepatitis B Immunization Data of Patients Living with HIV/AIDS: A Multi Centre Study. Central European Journal of Public Health, 30, 213-218. https://doi.org/10.21101/cejph.a7300
[24]
Comité National de lutte contre le VIH-Sida de la République Centrafricaine (CNLS) (2019) Rapport de l’étude sur l’estimation de la taille et la détermination du profil sérocomportemental lié aux IST/VIH au sein des professionnelles de sexe en République Centrafricaine en 2019. CNLS, Bangui.
[25]
Jobarteh, M., Malfroy, M., Peterson, I., Jeng, A., Sarge-Njie, R., Alabi, A., Peterson, K., Cotton, M., Hall, A., Rowland-Jones, S., Whittle, H., Tedder, R., Jaye, A. and Mendy, M. (2010) Seroprevalence of Hepatitis B and C Virus in HIV-1 and HIV-2 Infected Gambians. Virology Journal, 7, Article No. 230. https://doi.org/10.1186/1743-422X-7-230
[26]
Institut Centrafricain des Etudes Economiques et Sociales (ICASEES) (2019) Enquête par grappe à indicateurs Multiples 2018-2019 6th Edition (MICS 6). Rapport Final 2018-2019. ICASEES, Bangui. https://icasees.org/index.php/actualites/rapport-final-mics-2018-2019-en-francais
[27]
Magadi, M.A. (2011) Understanding the Gender Disparity in HIV Infection across Countries in Sub-Saharan Africa: Evidence from the Demographic and Health Surveys. Sociology of Health & Illness, 33, 522-539. https://doi.org/10.1111/j.1467-9566.2010.01304.x
[28]
Weitzel, T., Rodriguez, F., Noregia, L.M., Marcotti, A., Duran, L., Palavecino, C., Porte, L., Aguilera, X., Wolff, M. and Cortes, C.P. (2020) Hepatitis B and C Virus Infection among HIV Patient within the Public and Private Healthcare System in Chile: A Cross-Sectional Serosurvey 2020. PLOS ONE, 15, e0227776.
[29]
Vueba, A.N., Almendra, R., Santana, P., Faria, C. and do Céu Sousa, M. (2021) Prevalence of HIV and Hepatitis B Virus among Pregnant Women in Luanda (Angola): Geospatial Distribution and Its Association with Socio Demographic and Clinical Determinants. Virology Journal, 18, Article No. 239.
[30]
Firnhaber, C., Chen, C.Y., Evans, D., Maskew, M., Schulz, D., Reyneke, A. and Kramvis, A. (2012) Prevalence of Hepatitis B Virus (HBV) Co-Infection in HBV Serologically-Negative South African HIV Patients and Retrospective Evaluation of the Clinical Course of Mono-and Coinfection. International Journal of Infectious Diseases, 16, e268-e272.
[31]
Isa, I., Aminu, M., Abdullahi, S.A., Sani, M.A., Usman, M.A., Esona, M.D. and Ella, E.E. (2017) Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Infection among Students in Ahmadu Bello University, Zaria, Nigeria. Archives of Medical and Biomedical Research, 3, 77-90.
[32]
Longo, J.D.D., Mbeko, S.M., Camengo Police, S.P., Diemer, H.S.C., Brücker, G., Bélec, L. and Grésenguet, G. (2015) Forte Prévalence de l’Infection à VIH dans la Population des Hommes ayant des rapports sexuels avec d’autres hommes à Bangui, en République Centrafricaine. Health Sciences and Diseases, 16, 1-6.
[33]
Camengo Police, S.M., Mbeko Simaléko, M., Mossoro-Kpindé, C.D., Longo, J.D.D., Tekpa, G., Backo, A., Betchem, R., Gabouga, F., Sana, C., Gresenguet, G. and Belec, L. (2013) Prévalence de l’AgHBs chez les homosexuels masculins à Bangui. Médecine d’Afrique Noire, 60, 513-518.
[34]
Opaleye, O., Akanbi, O. and Binuyo, M. (2017). Prevalence of HBV, HIV, and HIV-HBV Co-Infections among Healthcare Workers in Ibadan, Nigeria. BMJ Global Health, 2, A1-A67.
